Angioedema is a skin reaction similar to urticaria. It is characterised by an abrupt, temporary, localised swelling of the deep dermal layer, subcutaneous tissue, and mucous membranes. Although it can affect any part of the body, it most often occurs around the eyes, lips, and genitals. In severe cases, the internal lining of the upper respiratory tract and intestines may also be affected.
There are multiple types of angioedema, including allergic, drug-induced, idiopathic, and hereditary angioedema (HAE).
Urticaria is the development of transient localised oedema in the dermis, characterised by wheals and often co-exists with angioedema. Wheals are usually superficial skin-coloured or pale swellings, surrounded by erythema.
Severe lip angioedema
Lid angioedema - there was typical urticaria elsewhere on the body
Urticaria is a common skin presentation, affecting up to 20% of people; an estimated 40% of patients with chronic urticaria (lasting over 6 weeks) have associated angioedema. The prevalence of hereditary angioedema is estimated to be 1 in 500,000.
ACE-inhibitor induced angioedema is rare, however, it is the sub-type most likely to result in hospitalisation and is more common in African-Americans.
What causes angioedema?
Angioedema is caused by an increase in local capillarypermeability and plasmaextravasation, usually mediated by mast cells, histamine, or bradykinin release.
Angioedema is most commonly histamine-mediated; mast cell and basophil stimulation results in histamine release. Angioedema with urticaria tends to suggest a histaminergic form, which includes acute allergic angioedema and histaminergic idiopathic angioedema. The exact cause depends on the type of angioedema a patient has.
Angioedema type
Causes
Acute allergic angioedema
(almost always occurs with urticaria within 1-2 hours of exposure to the allergen)
Food allergy, especially nuts, shellfish, milk, eggs
Inherited abnormal gene that causes a deficiency of a normal blood protein
3 types: Type 1 and II mutations of C1NH (SERPING1) gene on chromosome 11, encoding C1 inhibitor protein; Type III mutation in F12 gene on chromosome 12, encoding coagulation factor XII
Type 1 results in low levels and function of circulating C1 inhibitor; Type II has normal levels of C1 inhibitor protein but a reduction in function
Occurs in 1 in 50,000 males and females; Type III is more severe in women (associated with oestrogen)
Can occur spontaneously but may also be triggered by emotional stress, minor trauma such as dental procedures, and hormonal factors e.g. oestrogen derived medicines
Decreased C1 inhibitor activity leads to excessive kallikrein, which in turn produces bradykinin, a potent vasodilator
Acquired C1 inhibitor deficiency
Acquired during life rather than inherited
May be due to B-cell lymphoma or antibodies against C1 inhibitor
Associated with lymphoproliferative and autoimmune disease e.g. SLE
Localised vibratory urticaria is also due to a vibratory stimulus and is considered distinct from vibratory angioedema
What are the clinical features of angioedema?
General features include:
Localised oedema
Usually affecting eyelids or lips
Skin-coloured or slightly red in colour
Associated with burning sensation
Not itchy
Non-pitting
Swelling usually resolve within 24-48 hrs
Lesions do not weep or blister and resolve without scaling (in contrast to acute eczema)
May affect other organs such as:
Intestines — causing abdominal pain
Upper airway — producing difficulty in breathing and swallowing.
Angioedema type
Clinical features
Acute allergic angioedema
Almost always occurs with urticaria
Angioedema and urticaria both usually occur within 1-2 hours of exposure to an allergen (exception is ACE inhibitor-induced angioedema that usually occurs within the first week of treatment but can occur weeks to months later)
Reactions are usually self-limiting and subside within 1-3 days
Reactions will recur with repetitive exposures or exposure to cross-reactive substances
Non-allergic drug reaction
ACE inhibitor-induced angioedema occurs without urticaria
Likely to affect the face, lips, and tongue
Can be severe and require hospitalisation
Idiopathic/chronic angioedema
Similar to acute allergic angioedema but recurs and often no known cause is found
Hereditary angioedema
Patients often experience no symptoms until they reach puberty
Swellings can occur without any provocation by precipitating factors, including local trauma, vigorous exercise, emotional stress, alcohol, and hormonal factors (menstruation, pregnancy, oestrogen)
Some patients may get a transitory prodromal non-itchy rash, headache, visual disturbance or anxiety
Face, hands, arms, legs, genitals, digestive tract and airway may be affected; swellings spread slowly and may last for 3-4 days
Abdominal cramps, nausea, vomiting, difficulty breathing and rarely urinary retention from swelling of internal tracts
ie, rule out anaphylaxis as a life-threatening differential – sudden onset of symptoms, airway, breathing or circulation problems, signs of shock.
If hereditary angioedema is suspected, testing can find low C4 and C1-INH levels (part of the complement system). However, cases of HAE with normal C4 levels have been reported.
The prognosis of angioedema is dependent on the presentation, severity and the initiation of, and response to appropriate treatment.
Mild symptoms often self-resolve within 72 hours. However, angioedema can be life-threatening, particularly after insect bites and stings, and in hereditary and ACE-inhibitor induced angioedema if there is airway involvement. This requires emergency assessment and intervention.
Cicardi M, Aberer W, Banerji A. Classification, diagnosis and approach to treatment for angioedema: consensus report for the Hereditary Angioedema International Working Group. Eur J Allergy Clin Immunol. 2014; 69:602–16. DOI: 10.1111/all.12380. Journal
Depetri F, Tedeschi A, Cugno M. Angioedema and emergency medicine: from pathophysiology to diagnosis and treatment. Eur J Intern Med. 2019; 59: 8–13. DOI: 10.1016/j.ejim.2018.09.004. Journal
Kaplan AP. Angioedema. World Allergy Organ J. 2008;1(6):103–13. doi:10.1097/WOX.0b013e31817aecbe. PubMed
Misra L, Khurmi N, Trentman T. Angioedema: Classification, management and emerging therapies for the perioperative physician. Indian J Anaesth. 2016;60(8): 534–41. doi: 10.4103/0019-5049.187776. Journal
Powell R, Leech S, Till S, Huber P, Nasser S, Clark A. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015; 45: 547–65. Guideline
Radonjic-Hoesli S, Hofmeier K, Micaleto S, Schmid-Grendelmeier P, Bircher A, Simon D. Urticaria and Angioedema: an Update on Classification and Pathogenesis. Clin Rev Allergy Immunol. 2018; 54(1): 88–101. DOI: 10.1007/s12016-017-8628-1. Journal